Scholarlink

Purpose <p>To explore health outcomes of patients with ulcerative colitis (UC) and associated ocular inflammatory disease, compared to those of matched patients with UC without associated ocular inflammatory disease.</p> Design <p>Retrospective case-control study.</p> Methods <p>An aggregated electronic health records research network, TriNetX (Cambridge, MA, USA), was used to identify patients diagnosed with UC stratified by the presence or absence of ocular inflammatory disease with at least one year of follow-up. Propensity score matching (PSM) was performed to control for baseline demographics and medical comorbidities.</p> Main outcome measures <p>Rates and relative risk (RR) of developing various forms of intestinal complications, extraintestinal morbidities, rheumatologic disease, cardiovascular disease, and death.</p> Results <p>Patients with UC with associated ocular inflammatory disease showed greater risk of undergoing total colectomy, as well as acquiring <i>Clostridioides difficile</i> and CMV colitis. They also demonstrated a greater risk of developing MASLD, vitamin D deficiency, iron deficiency anaemia, UC-related dermatological disease, osteoporosis, and sepsis. These individuals were more likely to carry rheumatologic diagnoses, including ankylosing spondylitis, psoriatic, rheumatoid, enteropathic, reactive, and inflammatory arthritis. There was an elevated risk of stroke, myocardial infarction, and VTE in this cohort as well. There was no significant difference in risks of colorectal cancer, primary sclerosing cholangitis, toxic megacolon, non-radiographic axial spondyloarthritis, or mortality between the cohorts.</p> Conclusions <p>Patients with UC with ocular inflammatory disease have an increased risk of intestinal complications, extraintestinal morbidity, rheumatologic disease, and cardiovascular complications when compared to those without.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Risk of intestinal complications, extraintestinal morbidity, and mortality in patients with ulcerative colitis and ocular involvement

  • 期刊论文

  • 发表日期：

    2025年12月4日

查看全文
  • Brian K. Do,
  • Amer F. Alsoudi,
  • Karen M. Wai,
  • Euna Koo,
  • Ryan A. McConnell,
  • Nathan H. Pham,
  • Andrea L. Kossler,
  • Prithvi Mruthyunjaya,
  • Ehsan Rahimy

摘要

Purpose

To explore health outcomes of patients with ulcerative colitis (UC) and associated ocular inflammatory disease, compared to those of matched patients with UC without associated ocular inflammatory disease.

Design

Retrospective case-control study.

Methods

An aggregated electronic health records research network, TriNetX (Cambridge, MA, USA), was used to identify patients diagnosed with UC stratified by the presence or absence of ocular inflammatory disease with at least one year of follow-up. Propensity score matching (PSM) was performed to control for baseline demographics and medical comorbidities.

Main outcome measures

Rates and relative risk (RR) of developing various forms of intestinal complications, extraintestinal morbidities, rheumatologic disease, cardiovascular disease, and death.

Results

Patients with UC with associated ocular inflammatory disease showed greater risk of undergoing total colectomy, as well as acquiring Clostridioides difficile and CMV colitis. They also demonstrated a greater risk of developing MASLD, vitamin D deficiency, iron deficiency anaemia, UC-related dermatological disease, osteoporosis, and sepsis. These individuals were more likely to carry rheumatologic diagnoses, including ankylosing spondylitis, psoriatic, rheumatoid, enteropathic, reactive, and inflammatory arthritis. There was an elevated risk of stroke, myocardial infarction, and VTE in this cohort as well. There was no significant difference in risks of colorectal cancer, primary sclerosing cholangitis, toxic megacolon, non-radiographic axial spondyloarthritis, or mortality between the cohorts.

Conclusions

Patients with UC with ocular inflammatory disease have an increased risk of intestinal complications, extraintestinal morbidity, rheumatologic disease, and cardiovascular complications when compared to those without.